Centers for Education and Research on Therapeutics (CERTs)

The CERTs program is a national initiative to increase awareness of the benefits and risks of new, existing, or combined uses of therapeutics through education and research. CERTs research seeks to improve quality while reducing the cost of care by increasing appropriate use of pharmaceuticals and biological products and devices and by preventing adverse effects and consequences.

CERTs is supported by the Agency for Healthcare Research and Quality (AHRQ) in consultation with the Food and Drug Administration (FDA). Established in September 1999, the CERTs program builds on AHRQ's long history of research on pharmaceutical outcomes.

To learn more about the CERTs program and its current activities, go to the links below.

CERTs Second Annual Report
Provides information on the 7 CERTs centers and the 98 projects underway.

CERTs Findings on Treatment of ADHD and Depression (Press Release)
Highlights CERTs research finding increased use of drugs to treat attention-deficit/hyperactivity disorder (ADHD) and depression in young people.

CERTs Findings on Aspirin Use (Press Release)
Highlights study showing increased use of aspirin by patients with heart disease.

CERTs Web Site
Describes each CERTs center and gives information about projects, resources, and partners.

Return to AHRQ Home Page
Department of Health and Human Services